PSTCNN: Explainable COVID-19 diagnosis using PSO-guided self-tuning CNN.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 373, doi. 10.32604/biocell.2023.025905
- By:
- Publication type:
- Article
Works matching IS 03279545 AND DT 2023 AND VI 47 AND IP 2
Results: 18
1
2
ENST00000535926 is an unfavorable prognosis-related and tumorpromoting transcript of the CHPF gene in luminal A and B breast cancer.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 309, doi. 10.32604/biocell.2023.025377
- By:
- Publication type:
- Article
3
Effects of areca nut consumption on cell differentiation of osteoblasts, myoblasts, and fibroblasts.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 283, doi. 10.32604/biocell.2023.025743
- By:
- Publication type:
- Article
4
Magnetic mitohormesis: A non-invasive therapy for inflammatory disorders?
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 239, doi. 10.32604/biocell.2023.025357
- By:
- Publication type:
- Article
5
Gutmicrobiomemodulation: Ancillary effects of inorganic nanoparticles on gut microflora.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 245, doi. 10.32604/biocell.2023.025311
- By:
- Publication type:
- Article
6
dbSCI: A manually curated database of SARS-CoV-2 inhibitors for COVID-19.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 367, doi. 10.32604/biocell.2023.025310
- By:
- Publication type:
- Article
7
Methyltransferase 3A-mediated promoter methylation represses retinoic acid receptor responder 3 expression in basal-like breast cancer.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 319, doi. 10.32604/biocell.2023.025250
- By:
- Publication type:
- Article
8
The antioxidant trolox inhibits aging and enhances prostaglandin E-2 secretion in mesenchymal stem cells.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 385, doi. 10.32604/biocell.2023.025203
- By:
- Publication type:
- Article
9
Inhibition of H<sub>2</sub>O<sub>2</sub>-induced apoptosis of GC2-spg cells by functionalized selenium nanoparticles with lentinan through ROSmediated ERK/p53 signaling pathways.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 401, doi. 10.32604/biocell.2023.025154
- By:
- Publication type:
- Article
10
A pan-cancer analysis of the biological function and clinical value of BTLA in tumors.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 351, doi. 10.32604/biocell.2023.025157
- By:
- Publication type:
- Article
11
Correlations among core species corresponding to the clinical staging of periodontitis.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 431, doi. 10.32604/biocell.2023.024948
- By:
- Publication type:
- Article
12
The peptide fraction of Bothrops jararaca snake venom induces toxicological effects on the male reproductive system after local envenomation in mice.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 289, doi. 10.32604/biocell.2023.023787
- By:
- Publication type:
- Article
13
Hypoxia-induced reactive oxygen species in organ and tissue fibrosis.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 261, doi. 10.32604/biocell.2023.024738
- By:
- Publication type:
- Article
14
The role of 5'-adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle atrophy.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 269, doi. 10.32604/biocell.2023.023766
- By:
- Publication type:
- Article
15
Prognostic model for prostate cancer based on glycolysis-related genes and non-negative matrix factorization analysis.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 339, doi. 10.32604/biocell.2023.023750
- By:
- Publication type:
- Article
16
Maternal hyperthyroidism increases the synthesis activity and the osteogenic markers expression of calvarial osteoblasts from offspring in a murine model.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 423, doi. 10.32604/biocell.2023.023689
- By:
- Publication type:
- Article
17
Columbianetin acetate inhibits the occurrence and development of pancreatic cancer cells by down-regulating the expression of Meiotic nuclear divisions 1.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 297, doi. 10.32604/biocell.2023.023553
- By:
- Publication type:
- Article
18
Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma.
- Published in:
- Biocell, 2023, v. 47, n. 2, p. 329, doi. 10.32604/biocell.2023.023489
- By:
- Publication type:
- Article